Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome. [electronic resource] by
- Gaztanaga, Juan
- Farkouh, Michael
- Rudd, James H F
- Brotz, Tilmann M
- Rosenbaum, David
- Mani, Venkatesh
- Kerwin, Todd C
- Taub, Rebecca
- Tardif, Jean-Claude
- Tawakol, Ahmed
- Fayad, Zahi A
Producer: 20160105
In:
Atherosclerosis vol. 240
Availability: No items available.
|
|
14.
|
American Society of Nuclear Cardiology review of the ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI). [electronic resource] by
- Ward, R Parker
- Al-Mallah, Mouaz H
- Grossman, Gabriel B
- Hansen, Christopher L
- Hendel, Robert C
- Kerwin, Todd C
- McCallister, Benjamin D
- Mehta, Rupa
- Polk, Donna M
- Tilkemeier, Peter L
- Vashist, Aseem
- Williams, Kim Allan
- Wolinsky, David G
- Ficaro, Edward P
Producer: 20080122
In:
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology vol. 14
Availability: No items available.
|